Previous studies show that low birth weight is associated with an increased risk of later maternal cardiovascular disease (CVD). Earlier studies also indicate that preterm delivery (ie, before 37 weeks) may be associated with an increased maternal CVD risk. We examined the association between severity of preterm birth, fetal growth restriction, and later maternal incident hospitalization or death from coronary heart disease, heart failure, and cerebrovascular events taking measured potential confounders into account. We included 923 686 Swedish women giving their first singleton birth between 1983 and 2005. After accounting for maternal age, birth year, income, education, smoking, hypertension, and diabetes mellitus, we found that the risk for CVD was more than doubled in women delivering very or extremely preterm (before 32 and 28 weeks, respectively) compared with women delivering a term, non-small-for-gestational-age infant. In women delivering a smallfor-gestational-age infant, the CVD risk was doubled if the infant was born at 32 to 36 weeks and tripled if the infant was born before 32 weeks of gestation compared with women delivering a nonsmall Correspondence to The Editors, Circulation Editorial Office, Summary: There is a robust and consistent association between air pollution and cardiovascular morbidity and mortality. These harmful effects are most strongly associated with exposure to traffic-derived e152 Circulation
Summary: Food components are well known to affect cardiovascular risk, for which blood pressure, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and the inflammatory marker C-reactive protein (CRP) are established biomarkers. In the present randomized, multicenter study, the separate effects of 11 kg weight loss achieved during an 8-week low-calorie diet as well as a subsequent 26-week intake of diets varying in protein and glycemic index on these biomarkers were studied. The choice of food was ad libitum but was strictly controlled by nutritional advice concerning the targeted fat and protein content as well as glycemic index. Expectedly, the initial weight loss significantly reduced systolic and diastolic blood pressure, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and CRP. The subsequent consumption of different low-fat isocaloric diets resulted in moderate increases of blood lipids and blood pressure, which, however, were independent of the protein content and glycemic index of the diet. This clearly indicated that the beneficial effects on blood lipids and blood pressure were driven by the weight reduction itself but not by the dietary composition. In explicit contrast to the other biomarkers, consumption of low-glycemic-index diets led to a further decrease of CRP compared with high-glycemic-index diets. A low protein content enhanced the CRP-lowering effect, whereas a high protein content diminished it. Thus, the combination of low glycemic index and low protein intake appears to be most effective to reduce CRP, an established marker of low-grade inflammation and cardiovascular risk.
Conclusions: This large-scale intervention study clearly separates weight loss from dietary composition-related effects. Low-glycemicindex carbohydrates and, to a lesser extent, low-protein intake may specifically reduce low-grade inflammation and associated comorbidities in overweight/obese adults. 1
Combined Lifestyle Factors and Cardiovascular Disease Mortality in Chinese Men and Women: The Singapore Chinese Health Study
Summary: Lifestyle factors directly affect established and novel pathways of cardiovascular risk. Despite this evidence, few studies have examined the combined association of multiple lifestyle factors with cardiovascular disease (CVD) mortality. Furthermore, there has been little ethnic variation in the populations studied or examination of this topic in patients with a history of diabetes mellitus and/or CVD. Therefore, this study examined the combined association of lifestyle factors with CVD mortality and its major subgroups in healthy Chinese men and women and a high-risk subcohort with a history of diabetes mellitus and CVD during study enrollment in the Singapore Chinese Health Study (1993-98) and followed up through 2009. In 50 466 healthy and high-risk Chinese men and women, protective lifestyle factors were represented by a diet plentiful in vegetables, fruit, and soy; higher relative levels of physical activity; light to moderate alcohol consumption; average usual sleep of 6 to 8 hours/d; no history of smoking, and normal weight (ie, not underweight or overweight). In combination, a marked decrease in rate and risk of dying as a result of CVD was observed with each additional protective lifestyle factor in healthy and high-risk participants. Overall, data from this large cohort of Chinese adults highlight that multiple modifiable lifestyle factors are of paramount importance in improving population-wide cardiovascular risk reduction in both primary and secondary prevention. Efforts to increase the prevalence of protective lifestyle factors in healthy and high-risk populations should significantly influence CVD mortality.
Conclusion: An increasing number of protective lifestyle factors is associated with a marked decreased risk of coronary heart disease, cerebrovascular disease, and overall CVD mortality in Chinese men and women. 2 infant at term. In analyses restricted to women for whom prepregnancy body mass index data were available (Nϭ670 934), additional adjustment for body mass index did not attenuate the CVD risk. Our findings suggest that a preterm or small-for-gestational-age birth is an early indicator of later maternal CVD risk. If primary cardiovascular prevention measures are undertaken in women with a history of a preterm or small-for-gestational age birth, it might lower their CVD risk and improve the outcome of the next pregnancy.
Conclusions: Delivery of a preterm or small-for-gestational-age infant is associated with later life maternal hospitalization or death from CVD even after accounting for socioeconomic factors, smoking, and pregnancy-related complications. 3 
Long-Term Effects of Changes in Cardiorespiratory Fitness and Body Mass Index on All-Cause and Cardiovascular Disease Mortality in Men: The Aerobics Center Longitudinal Study
Summary: If overweight or obese persons, who comprise two thirds of the US population, can reduce the risk of premature mortality by improving physical activity or fitness, this carries a large clinical and public health implication. Studies of cardiorespiratory fitness (hereafter fitness) change and mortality are sparse, and long-term effects of body mass index (BMI) change on mortality are inconsistent. Also, the combined associations of changes in fitness and BMI with mortality remain controversial and uncertain. This study found that maintaining or improving fitness was associated with a lower risk of death from both all-causes and cardiovascular disease in 14 345 men during 11.4 years of follow-up, after accounting for possible confounding effects of baseline risk factors, changes in lifestyle factors and medical conditions, and simultaneous BMI change. Men who lost fitness also had a higher mortality risk regardless of BMI change in our combined analyses. Given the great difficulties of losing weight and maintaining a reduced weight over the long term, this study underscores the benefits of maintaining and improving fitness to reduce mortality risk independent of weight change, and is important for the development of health recommendations and policies. To date, extensive attention has been given to weight loss. However, the long-term effect of fitness change, primarily resulting from increasing physical activity, is likely to be at least as important as weight loss for reducing premature mortality. Increased attention needs to be placed on strategies to maintain or improve fitness.
Conclusions:
Maintaining or improving fitness is associated with a lower risk of all-cause and CVD mortality in men. Preventing age-associated fitness loss is important for longevity regardless of BMI change. 4
High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation
Summary: Lower-extremity peripheral artery disease (PAD) is a manifestation of atherosclerosis that has received considerably less clinical and research attention than coronary or cerebrovascular disease. PAD shares many risk factors with other cardiovascular diseases, including smoking, diabetes mellitus, hypertension, and hyperlipidemia; however, less is known about how PAD differs from atherosclerosis of other vascular territories. Studies of biomarkers and future disease risk can improve our ability to detect patients at heightened risk and our understanding of disease pathogenesis and, by extension, may identify potential novel modalities for treatment. Adiponectin is secreted from adipose tissue and is known to be inversely correlated with future diabetes mellitus risk. It may also be antiatherogenic. This study is the first to examine the relationship between adiponectin and PAD as a specific vascular end point. A large population of initially healthy women aged ł45 years without existing cardiovascular disease was studied. After traditional cardiovascular risk factors were taken into account, women with highmolecular-weight or total adiponectin levels in the highest tertile had a 59% (high-molecular-weight) or 63% (total) reduced risk for future symptomatic PAD (intermittent claudication or lower-extremity revascularization) compared with women with levels in the lowest tertile. Given the lack of a consistently demonstrated relationship between adiponectin and other cardiovascular end points, this striking result, if confirmed, suggests a unique relationship of adiponectin in PAD development that may reflect a more prominent role of adipokines in peripheral atherosclerosis.
Conclusions: Total and high-molecular-weight adiponectin are inversely associated with incident PAD among initially healthy women. These prospective data support a protective role for this adipokine in peripheral atherosclerosis development. 5
Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
Summary: Homozygous familial hypercholesterolemia (HoFH) is an inherited disorder usually caused by mutations in both low-density lipoprotein receptor alleles, which results in extremely elevated plasma low-density lipoprotein cholesterol concentrations and very early morbidity and mortality due to cardiovascular disease. Untreated, HoFH patients rarely survive beyond the third decade. This retrospective study reports the effect of lipid-lowering treatment, mainly statin therapy, on survival and time to first major cardiovascular event in a large cohort of HoFH patients who have been followed up for up to 40 years. Despite achieving a mean reduction in low-density lipoprotein cholesterol of only 26%, lipid-lowering therapy was associated with delayed cardiovascular events and prolonged survival in patients with HoFH. This supports the mounting evidence of the remarkable benefit of lipid-lowering therapy, particularly statin therapy, and establishes that lowering low-density lipoprotein cholesterol can prolong life even in HoFH. This analysis also highlights the importance of early diagnosis and initiation of lipid-lowering therapy, especially in young children with HoFH, to delay the onset of cardiovascular disease.
Conclusions: Lipid-lowering therapy is associated with delayed cardiovascular events and prolonged survival in patients with homozygous familial hypercholesterolemia. 6
Insomnia and the Risk of Acute Myocardial Infarction: A Population Study
Summary: Insomnia, a subjective feeling of having difficulties initiating or maintaining sleep, or having a feeling of nonrestorative sleep, is a highly prevalent condition in the industrialized world. Only a few prospective studies have investigated insomnia in relation to risk for coronary heart disease, and these prior studies have been subjected to several potential methodological limitations. We assessed insomnia symptoms and risk of acute myocardial infarction in a large population-based study, taking into account the established cardiovascular risk factors, psychological distress, and chronic somatic disorders. In our study, insomnia symptoms were associated with a moderate increase in risk for acute myocardial infarction. The results were fairly robust in different multivariable models and sensitivity analyses. Nevertheless, insomnia is a frequent, easily recognizable, and potentially manageable condition. Treatment options include adherence to simple recommendations concerning sleeping habits, often referred to as sleep hygiene, and several nonpharmacological and pharmacological therapies, with the potential to produce reliable and durable changes among persons who have chronic insomnia. Therefore, evaluation of insomnia might provide additional information in clinical risk assessment that could be useful in cardiovascular prevention.
However, further research is needed to better establish the risk associated with insomnia and to reveal the possible pathophysiological mechanisms.
Conclusions: Insomnia is associated with a moderately increased risk for acute myocardial infarction. 7
Pregnancy Outcomes in Familial Hypercholesterolemia: A Registry-Based Study
Summary: Women with familial hypercholesterolemia (FH) are prone to early cardiovascular disease and death. Approximately 1:300 people are affected with FH in Norway. Lipid-lowering medication, with the exception of resins, is contraindicated during pregnancy. Stopping lipid-lowering medication may lead to a 40% to 50% increase in low-density lipoprotein (LDL) cholesterol. In addition, a 30% increase in LDL cholesterol and an approximate doubling in fasting triglycerides can also be expected. Because it is unknown whether FH adversely affects pregnant women and their birth outcomes in clinical terms, we analyzed 2319 births of 1093 women with FH. Firstly, this study shows that women with FH do not have an increased risk for prematurity (birth Ͻ gestational week 37), low birth weight (Ͻ2500 g), or frequency of congenital malformations. The results from the present study may thus be reassuring for FH women in childbearing age and their obstetricians. Secondly, some previous reports suggested that women with elevated cholesterol by itself, without FH, are at risk for adverse pregnancy outcomes. In this view, women with FH represent nature's own experiment to test if elevated LDL cholesterol is responsible for adverse pregnancy outcomes. Data from this study show that a genetically determined elevated LDL cholesterol does not negatively affect pregnancy outcome, and therefore suggest that elevated LDL cholesterol per se may not influence pregnancy outcome.
Conclusions: Women with FH do not appear to have a higher risk of preterm delivery or of having infants with low birth weight or congenital malformations than women in general, but, although this is unlikely, some undetected bias may obscure the real differences. 8
Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis
Summary: It is well established that heart diseases such as atrial fibrillation increase the risk of arterial embolism. However, whether heart diseases similarly increase the risk of pulmonary embolism without peripheral venous thrombosis is less certain. Using Danish medical databases, we conducted a nationwide population-based case-control study of 45 282 patients with embolism alone, 4680 patients with pulmonary embolism and lower-limb deep venous thrombosis, 59 790 with deep venous thrombosis alone, and 541 561 population controls. Myocardial infarction and heart failure in the preceding 3 months conferred remarkably high risks of apparently isolated pulmonary embolism, with odds ratios of 43.5 (95% confidence interval, 39.6 -47.8) and 32.4 (95% confidence interval, 29.8 -35.2), respectively. There was a particularly strong association of right-sided valvular disease with isolated pulmonary embolism (odds ratio, 74.6; 95% confidence interval, 28.4 -195.8 ). We conclude that heart disease is associated with an increased short-term risk of venous thromboembolism, including isolated pulmonary embolism. Because common heart diseases may directly account for the development of pulmonary embolism, in patients with pulmonary embolism and no apparent deep venous thrombosis, cardiac sources of emboli should be considered and appropriate treatment instituted.
Conclusion: Heart diseases increase the near-term risk for pulmonary embolism not associated with diagnosed peripheral vein thrombosis. 9
Association of Incident Cardiovascular Disease With Periodic Limb Movements During Sleep in Older Men: Outcomes of Sleep Disorders in Older Men (MrOS) Study
Summary: Periodic limb movements during sleep (PLMS) are a frequent finding of overnight polysomnography, especially in the elderly; however, the clinical significance of these movements is not clear. In this article, when data from the Outcomes of Sleep Disorders in Older Men (MrOS) sleep cohort were analyzed, PLMS were associated with an increased risk of incident cardiovascular disease in elderly men. In this analysis, PLMS preceded the development of cardiovascular disease, which suggests but does not prove a causal role for PLMS in vascular disease. The mechanism behind this increased cardiovascular risk may be associated with the known sympathetic hyperactivity associated with PLMS. The association between incident arterial disease and PLMS was particularly robust, suggesting that arterial disease may result from PLMS. In the not too distant future, PLMS frequency noted on the polysomnography report, like the apnea-hypopnea index, may become a useful metric on how to judge a patient's cardiovascular risk. Additional study is needed to clarify this relationship between PLMS and cardiovascular risk and furthermore to see whether treating PLMS decreases this risk.
Conclusion: These findings provide evidence that PLMS frequency is associated with incident cardiovascular disease in communitydwelling elderly men. 10
Marine n-3 Polyunsaturated Fatty Acids in Adipose Tissue and the Risk of Acute Coronary Syndrome
Summary: Previous studies have shown that intake of marine n-3 polyunsaturated fatty acids (PUFAs) has a beneficial effect on coronary mortality, especially among patients already diagnosed with coronary disease. The effects of marine n-3 PUFAs on nonfatal coronary disease and in healthy subjects have, however, been inconsistent. This may be explained by the use of heterogeneous methods to assess the intake of marine n-3 PUFAs. The content of marine n-3 PUFAs in adipose tissue has been reported to be a good and objective marker for long-term dietary intake of n-3 PUFAs. In a cohort study including 57 053 healthy subjects, we investigated the content of n-3 PUFAs in adipose tissue among 1012 cases with incident acute coronary syndrome during the study period of 7.6 years and in a random sample of the cohort (nϭ1630). We found negative dose-response associations between the content of marine n-3 PUFAs and the risk of acute coronary syndrome among men, whereas no consistent associations were found among women. These results support the hypothesis that dietary intake of marine n-3 PUFAs may protect against acute coronary syndrome in healthy men and therefore support the recommendation by the American Heart Association and the European Society of Cardiology to eat fish, especially oily fish (the primary source of dietary n-3 PUFAs), at least twice a week.
Conclusion: Intake of marine n-3 polyunsaturated fatty acids may protect against acute coronary syndrome in men. 11
Low Prevalence of Abdominal Aortic Aneurysm Among 65-Year-Old Swedish Men Indicates a Change in the Epidemiology of the Disease
Summary: On the basis of results from 4 randomized controlled trials, screening elderly men with ultrasound for abdominal aortic aneurysm (AAA) has emerged as an evidence-based way of reducing mortality from ruptured AAA. Although no trial has assessed the optimum age for AAA screening, current recommendations generally consist of a 1-time ultrasound examination at 65 years of age. In
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this contemporary population-based AAA screening study of a large cohort of 65-year-old Swedish men, a lower-than-expected AAA prevalence was found. This was attributed mainly to a changed exposure to known risk factors over the past decades, particularly a significant decline in smoking. At the same time, the life expectancy of the target population has increased significantly while the surgical caseload of AAA has remained unchanged. These observed changes in the epidemiology of AAA disease highlight the need to reevaluate different screening strategies on the basis of modern epidemiological data, which may influence the design of future screening programs.
Conclusions: On the basis of the observed reduced exposure to risk factors, lower-than-expected prevalence of AAA among 65-year-old men, unchanged AAA repair rate, and significantly improved longevity of the elderly population, the current generally agreed-on AAA screening model can be questioned. Important issues to address are the threshold diameter for follow-up, the possible need for rescreening at a higher age, and selective screening among smokers. 12
Effect of Torcetrapib on Glucose, Insulin, and Hemoglobin A 1c in Subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
Summary: High-density lipoproteins have antidiabetic properties in vitro. Furthermore, the elevated high-density lipoprotein levels accompanying a genetic deficiency of cholesteryl ester transfer protein (CETP) are associated with decreased levels of plasma glucose. It is therefore possible that inhibition of CETP and the associated increase in concentration of high-density lipoprotein cholesterol may improve diabetic control. We tested this possibility in a post hoc analysis of the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial and found that, despite the overall adverse outcome of the trial, treatment with the CETP inhibitor torcetrapib resulted in a highly significant improvement in glycemic control in patients with type 2 diabetes mellitus. Whether this effect of torcetrapib was due to CETP inhibition and the associated increase in concentration of high-density lipoprotein or to a (beneficial) off-target effect of the drug cannot be determined from this analysis. Such a possibility will have to await the results of ongoing trials with other CETP inhibitors such as dalcetrapib and anacetrapib that do not share the adverse effects of torcetrapib. If treatment with dalcetrapib and anacetrapib is found to be both antidiabetic and cardioprotective, there will be a compelling case for considering CETP inhibition as a treatment of choice in patients with type 2 diabetes mellitus.
Conclusions: Treatment with torcetrapib improves glycemic control in atorvastatin-treated patients with type 2 diabetes mellitus. It remains to be determined whether this effect is the consequence of raising high-density lipoprotein. 13
Exploring Determinants of Secular Decreases in Childhood Blood Pressure and Hypertension
Summary: The dramatic reduction in mortality from stroke and coronary heart disease observed over several decades in many countries is due partly to declines in blood pressure (BP) and hypertension. 
Conclusions:
We observed important population declines in blood pressure in Korea over a 10-year period in children 10 to 19 years of age, but the likely causes for these secular trends remain to be determined. 14
Association Between Myocardial Infarction and Fractures: An Emerging Phenomenon
Summary: Accumulating evidence links atherosclerotic disease to osteoporosis, but the specific association between myocardial infarction (MI) and fractures has rarely been studied, and temporal trends have not been evaluated. Using data spanning 30 years (1979 -2009), originating from carefully characterized cohorts (3321 consecutive incident MI patients and 3321 community-based non-MI control subjects individually matched on age, sex, and year of onset) with complete ascertainment of fractures, we detected a steady increase in osteoporotic fracture risk after MI, a novel finding not observed in the general population. This alarming temporal trend was robust across patient groups and fracture sites and is consistent with the displacement of post-MI outcomes toward noncardiovascular events. Thus, fracture prevention initiatives after MI are likely warranted, particularly among high-risk patient groups, such as the elderly, women, and those with prior fracture and/or coexisting illnesses. Furthermore, frailty symptoms, which are frequently overlooked in the traditional disease-specific model of cardiac care applied to MI patients, should be assessed and treated. Participation in secondary prevention programs should be aggressively pursued given the beneficial role of physical activity for the prevention of bone loss and falls, crucial elements in fracture prevention.
Conclusions: Over the past decades, the association between MI and osteoporotic fractures increased steadily. The trend is consistent with the displacement of post-MI outcomes toward noncardiovascular events, highlighting the need for comprehensive prevention strategies to accommodate the changing epidemiology of MI. 15
Mortality and Readmission of Patients With Heart Failure, Atrial Fibrillation, or Coronary Artery Disease Undergoing Noncardiac Surgery: An Analysis of 38 047 Patients
Summary: Heart failure (HF), coronary artery disease (CAD) and atrial fibrillation (AF) are the 3 most common chronic cardiovascular conditions, affecting a broad cross-section of the population. An increasing number of patients with HF, CAD, and AF survive longer and undergo noncardiac surgery. Although the perioperative risk for the patients with CAD has been well described, the risk for patients with HF or AF is less well defined. Using a cohort of Ͼ37 000 patients with HF, CAD, or AF from Alberta, Canada, we found that the risk for 30-day postoperative mortality was 3 times higher for those with HF compared with those with CAD, and nearly twice as high for AF compared with CAD. This difference persisted even after adjustment for patient and hospital variables. Even minor procedures carried significantly more risk than previously appreciated. Although current perioperative risk prediction models place e150 Circulation September 4, 2012 greater emphasis on CAD than HF or AF, patients with HF or AF have a significantly higher risk of postoperative mortality than patients with CAD.
Conclusions: Although current perioperative risk prediction models place greater emphasis on CAD than HF or AF, patients with HF or AF have a significantly higher risk of postoperative mortality than patients with CAD, and even minor procedures carry a risk higher than previously appreciated. 16
Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004
Summary: Cardiovascular disease remains a major cause of morbidity and mortality in the United States. Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis that confers a significantly increased risk of myocardial infarction, stroke, and death. Whether cardiovascular risk can be reduced by implementation of secondary prevention therapies (such as antiplatelet therapy, statins, or angiotensin-converting enzyme inhibitors/angiotensin receptor blockers) in individuals with PAD identified by a screening ankle-brachial index measurement is unknown. Using data from the National Health and Nutrition Examination Survey (NHANES), we demonstrate that millions of high-risk US adults with PAD (anklebrachial index £0.90) were not receiving guideline-recommended secondary prevention therapies. All-cause mortality was significantly higher in individuals with PAD, including those without previously recognized cardiovascular disease. Furthermore, treatment with multiple secondary prevention therapies was associated with significantly reduced risk of all-cause mortality in this population. Given the conflicting literature about the use of secondary prevention therapies, aspirin in particular, in patients with PAD, these observational findings underscore the importance of a largescale clinical trial to determine whether implementation of multiple secondary prevention therapies specifically in high-risk individuals identified by ankle-brachial index screening as having PAD can indeed reduce cardiovascular morbidity and mortality.
Conclusions: Millions of US adults with PAD are not receiving secondary prevention therapies. Treatment with multiple therapies is associated with reduced all-cause mortality. 17
Chronic Kidney Disease Is Associated With the Incidence of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
Summary: Previous research has shown that individuals with endstage renal disease have a higher risk of developing atrial fibrillation, and some cross-sectional studies have found higher prevalence of atrial fibrillation among those with decreased kidney function. However, evidence from prospective studies in the general population is limited. In an analysis of 10 328 men and women participating in the Atherosclerosis Risk in Communities Study, we observed that impaired kidney function, measured by lower cystatin-based or creatinine-based estimated glomerular filtration rate, was strongly associated with a higher risk of atrial fibrillation. Similarly, individuals with increased levels of urinary albumin-to-creatinine ratio, a marker of kidney damage, had a higher risk of developing atrial fibrillation. Our study highlights the potential role of chronic kidney disease as a risk factor for atrial fibrillation. Interventions aimed at preventing and treating chronic kidney disease could also contribute to reduce the burden of atrial fibrillation in the population.
Conclusion:
In this large population-based study, reduced kidney function and presence of albuminuria were strongly associated with the incidence of AF independently of other risk factors. 18
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
Summary: Most guidelines for treatment of hypertension, including the seventh report of the Joint National Committee, recommend an aggressive blood pressure goal of Ͻ130/80 mm Hg for patients with diabetes mellitus. However, the evidence on which the guidelines are based is limited. In our analyses of 13 randomized trials with 37 736 participants, we noted that in patients with type 2 diabetes mellitus, a systolic blood pressure treatment goal of 130 to 135 mm Hg is acceptable. However, with more aggressive goals (Ͻ130 mm Hg), we observed target organ heterogeneity in that the risk of stroke continued to fall, but there was no benefit regarding the risk of other macrovascular or microvascular (cardiac, renal, and retinal) events, and the risk of serious adverse events even increased.
Conclusions:
The present body of evidence suggests that in patients with type 2 diabetes mellitus/impaired fasting glucose/impaired glucose tolerance, a systolic blood pressure treatment goal of 130 to 135 mm Hg is acceptable. However, with more aggressive goals (Ͻ130 mm Hg), we observed target organ heterogeneity in that the risk of stroke continued to fall, but there was no benefit regarding the risk of other macrovascular or microvascular (cardiac, renal and retinal) events, and the risk of serious adverse events even increased. 19
Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study
Summary: Cardiac troponin is the preferred marker of myocardial necrosis in patients with acute coronary syndromes, and a strong predictor of adverse outcome in patients with chronic heart failure or coronary heart disease. However, troponin is rarely detectable in healthy patients when conventional assays are used. Whether very low levels of troponin detected by a novel high-sensitivity assay are associated with adverse outcomes in otherwise healthy diabetic and nondiabetic women has not been well studied. Using a new, highly sensitive assay for cardiac troponin T, we found that a higher proportion of diabetic women (45.5%) than nondiabetic women (30.3%) had detectable levels of cardiac troponin. Among diabetic women, the presence of a detectable troponin was associated with a 79% increase in the risk of incident cardiovascular disease (nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death) after adjusting for traditional cardiovascular risk factors and hemoglobin A1c. This increased risk in diabetic women appeared to be driven by a 3-fold increase in the risk of cardiovascular death. By contrast, no increase in cardiovascular risk was observed among women without diabetes mellitus. These data raise the possibility that high sensitivity troponin could serve as a complimentary marker of cardiovascular risk and a means of further risk stratification in women with diabetes mellitus.
Conclusions: Very low but detectable levels of cardiac troponin T are associated with total cardiovascular disease and cardiovascular disease death in women with diabetes mellitus. Among healthy nondiabetic women, detectable compared with undetectable troponin was not associated with cardiovascular disease events. 20
Birth Weight Predicts Risk of Cardiovascular Disease Within Dizygotic But Not Monozygotic Twin Pairs: A Large Population-Based Co-Twin-Control Study
Summary: Weight at birth has consistently been shown to predict risk of cardiovascular disease (CVD). When considering birth weight
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as a proxy for the fetal environment, this has prompted theories of early life determinants of adult disease. Although this field of research has come to include exposures that may be independent of birth weight, the underlying mechanisms of the original association remain to be elucidated. Birth weight has many determinants, which, if also involved in CVD development, could explain the association between the two. Since twin siblings share early environment and a varying degree of genetic factors, assessing the association between birth weight and risk of CVD within twin pairs offers unique possibilities to explore the influence from these factors. In this study, we identified 1942 twin pairs discordant for CVD in a population-based cohort of like-sexed twins born in Sweden 1926 to 1958. Birth weight was found to be inversely associated with risk of CVD within dizygotic, but not monozygotic twin pairs. Similar to previous findings in singletons, associations were seen for both coronary heart disease and ischemic stroke, but only within dizygotic twin pairs. Our study thus lends no support for an association between birth weight and CVD in the absence of genetic differences. We believe these findings make an important contribution to the understanding of early life influence on adult disease, by indicating that the association between birth weight and CVD could be a result of common causes.
Conclusions:
We found an association between birth weight and risk of cardiovascular disease within disease-discordant dizygotic but not monozygotic twin pairs. This indicates that the association between birth weight and cardiovascular disease could be a result of common causes, and that factors that vary within dizygotic but not monozygotic twin pairs may help identify them. 21
Sex and Race Differences in Right Ventricular Structure and Function: The Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study
Summary: Right ventricular (RV) morphology is an important predictor of outcomes in heart and lung disease; however, demographic differences in RV structure or function have not been studied. We found that age, sex, and race/ethnicity had important associations with RV mass and volumes and RV ejection fraction. These associations may explain differences in outcomes in a variety of common heart and lung diseases that affect the RV. We derived normative equations for RV parameters that could be used to define and diagnose RV dysfunction in adults of various races and ethnicities in research and clinical practice.
Conclusion: Age, sex, and race are associated with significant differences in RV mass, RV volumes, and RV ejection fraction, potentially explaining distinct responses of the RV to cardiopulmonary disease. 22
Ethnic Differences in Out-of-Hospital Fatal Pulmonary Embolism
Summary: This report presents the first epidemiological study involving a large number of autopsy-based out-of-hospital fatal pulmonary embolism investigations in New York City, with its diverse ethnic population. New data presented should alert and aid clinicians in evaluating patients at risk for acute and fatal pulmonary embolism on the basis of different ethnic backgrounds. Because blacks and Hispanics suffer fatal pulmonary embolism at a significantly younger age than whites, physicians should closely monitor these populations for known risk factors (such as body mass index) and counsel healthy lifestyles, especially at younger ages. Because of the large number of prothrombin G2010A carriers observed in white and Hispanic out-of-hospital pulmonary embolism decedents, testing for prothrombin G20210A in high-risk patients is indicated. Finally, our results clearly point to the need for additional research to identify other genetic causes of fatal pulmonary embolism, especially in blacks, who have low frequencies of known genetic risk factors.
Conclusion: There are unique epidemiological differences in out-ofhospital fatal pulmonary embolism between ethnic groups in New York City. 23
Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults: The Rancho Bernardo Study
Summary: The goal of risk stratification for primary prevention of cardiovascular disease is to identify individuals who may be candidates for interventions that could improve outcomes. Current risk stratification tools remain imperfect, and biomarkers that reflect novel pathophysiological pathways could improve risk assessment as well as provide insight into potential therapeutic targets. Growth differentiation factor-15 (GDF-15) is a divergent member of the transforming growth factor-b cytokine superfamily that is upregulated in the myocardium after ischemic injury. Previous communitybased studies have shown that higher levels of GDF-15 are associated with prevalent cardiovascular disease. The present study of older community-dwelling adults free of known cardiovascular disease from the Rancho Bernardo Study evaluated the association of GDF-15 levels with cardiovascular outcomes and mortality and found that GDF-15 was a robust predictor of all-cause, cardiovascular, and noncardiovascular mortality even after adjustment for traditional cardiovascular disease risk factors, renal function, and body size. In models containing all 3 markers, both GDF-15 and N-terminal pro-B-type natriuretic peptide, but not C-reactive protein, added incremental value for prediction of cardiovascular and allcause mortality. When associations are confirmed in other cohorts and when further studies clarify the mechanism of action, GDF-15 may ultimately be a worthy target for therapeutic interventions to prevent cardiovascular and all-cause death.
Conclusions: Growth differentiation factor-15 is a strong predictor of all-cause, cardiovascular, and noncardiovascular mortality in community-dwelling older individuals, adding incremental value to traditional risk factors and to NT-proBNP and C-reactive protein levels. 24
Atrial Fibrillation and Death After Myocardial Infarction: A Community Study
Summary: Atrial fibrillation (AF) often coexists with myocardial infarction (MI), yet its prognostic influence is in dispute. Prior reports studied the role of AF during the early hospitalization for acute MI on the risk of death and could not address the timing of AF in relation to the MI. Furthermore, the applicability of existing data to the community was uncertain. We assessed the occurrence of AF among MI patients, determined whether it has changed over time, and quantified its impact on mortality after MI. Among 3220 patients hospitalized with incident (first-ever) MI from 1983 to 2007 in the community, AF preceding MI was identified in 304 patients, and 729 developed AF after MI. The cumulative incidence of AF after MI at 5 years was 19%, and did not change over the calendar year of MI (the incidence of AF was the same regardless of when the MI occurred). During follow-up, 1638 deaths occurred, and AF was associated with a large increase in risk of death, independently of clinical characteristics at the time of MI and heart failure. This risk was the greatest for AF occurring later after the MI. Thus, in the community, AF is frequent in the setting of MI and carries an excess risk of death.
Conclusions: In the community, AF is frequent in the setting of MI. Atrial fibrillation carries an excess risk of death, which is the highest for AF developing Ͼ30 days after MI. 25 fine particles that predominantly originate from diesel engine exhaust emissions. Using a purpose-built exposure chamber, we have demonstrated previously the adverse vascular and prothrombotic effects of exposure to diesel exhaust in healthy men. In the present study, using complementary and relevant measures of cardiovascular health, we have reconfirmed the adverse effects of exposure to diesel engine exhaust on endothelial function and ex vivo thrombosis. In addition, for the first time, we demonstrate that reducing the particulate component of diesel exhaust with a commercially available particle trap can prevent these detrimental cardiovascular effects. Our study provides support for the application of particle traps to diesel-powered vehicles to reduce urban particulate concentrations and limit a range of adverse cardiovascular effects related to exposure to traffic-derived air pollution.
Conclusions: Exhaust particle traps are a highly efficient method of reducing particle emissions from diesel engines. With a range of surrogate measures, the use of a particle trap prevents several adverse cardiovascular effects of exhaust inhalation in men. Given these beneficial effects on biomarkers of cardiovascular health, the widespread use of particle traps on diesel-powered vehicles may have substantial public health benefits and reduce the burden of cardiovascular disease. 26
Use of Angiotensin Receptor Blockers and the Risk of Cancer
Summary: A meta-analysis of randomized trials published in June 2010 suggested that use of angiotensin receptor blockers (ARBs) may be associated with an increased risk of cancer, lung cancer in particular. Because millions of patients use ARBs, monitoring their safety is of immediate clinical importance. Using individual-level data from registries in Denmark, including, for example, information on filled drug prescriptions and cancer diagnoses, we conducted a nationwide cohort study to compare the rates of incident cancer among users of ARBs and angiotensin-converting enzyme inhibitors.
In an analysis including Ͼ100 000 users of ARBs and Ͼ200 000 users of angiotensin-converting enzyme inhibitors, we found no evidence of an increased risk of cancer overall associated with ARB use. Confidence intervals were narrow, allowing exclusion of a 4% increase in the risk of cancer. Results were similar when ARBs were compared with other antihypertensive drugs in a sensitivity analysis. In a subgroup analysis, there was no significant association between ARBs and lung cancer. Furthermore, although the angiotensin receptor system is involved in the process of carcinogenesis, experimental data point, if anything, toward beneficial effects of angiotensin signaling inhibition. Strengths of our study include the use of individual-level nationwide registry data and a comprehensive pharmacoepidemiological design. Clinicians can continue to prescribe ARBs without concern about an excess risk of cancer.
Conclusion:
In this large nationwide cohort, use of ARBs was not significantly associated with increased risk of incident cancer overall or of lung cancer. 27
Incidence of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
Summary: This report more accurately estimates the incidence of sudden cardiac death (SCD) in athletes using improved methodology compared with previous studies. It demonstrates an overall rate of SCD of 1:43 000, with some subpopulations showing a risk of SCD as high as 1:3000. The rate of SCD has been commonly cited as 1:200 000. From a clinical perspective, this is critically important information. The preparticipation examination, or sports physical, is a core part of the practice of sports medicine and primary care physicians alike. The purpose of the preparticipation examination, according to the latest AHA scientific statement, is to identify conditions that may lead to SCD. The current recommendation of the AHA is that this is best done, in the United States, by the use of a directed history and physical examination. There is increasing evidence that this strategy is neither effective nor cost-effective. In other countries, an ECG is a routine part of a sports physical, or in some cases a well-child visit. The information presented in this report will inform the ongoing discussion about SCD in young people and how best to prevent it. There may be subpopulations of athletes or young people in which screening with an ECG by use of modern interpretation criteria would be highly cost-effective, and others in which it would not. This report will have significant ramifications for clinical practice as we strive to understand how to best use our resources, fulfill the primary objective of the sports physical, prepare for sudden cardiac arrest, and ultimately prevent SCD.
Conclusions: SCD is the leading medical cause of death and death during exercise in NCAA student-athletes. Current methods of data collection underestimate the risk of SCD. Accurate assessment of SCD incidence is necessary to shape appropriate health policy decisions and develop effective strategies for prevention. 28
Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors: The Atherosclerosis Risk in Communities (ARIC) Study
Summary: This study, which is based on Ͼ17 years of follow-up of Ͼ14 500 men and women, represents an important contribution to the literature on the major and modifiable causes of atrial fibrillation (AF). Atrial fibrillation is an important risk factor for stroke and overall mortality and affects between 0.4% and 1.0% of the US population. Unlike other forms of cardiovascular disease, information about the preventable burden of AF is lacking. Therefore, the aim of this study was to determine what proportion of the burden of AF in blacks and whites could theoretically be avoided by the maintenance of an optimal risk profile. Previously established modifiable AF risk factors, namely high blood pressure, elevated body mass index, diabetes mellitus, cigarette smoking, and prior cardiac disease, were categorized into optimal, borderline, and elevated levels. On the basis of their risk factor levels, individuals were classified into 1 of these 3 groups. Overall, 57% of AF cases could be explained by having ł1 borderline or elevated risk factors, of which suboptimal blood pressure was the most important contributor, accounting for one quarter of the burden of AF. In comparison, only 3% of AF cases were attributable to diabetes mellitus. These findings illustrate that, as with other forms of cardiovascular disease, more than half of the AF burden is potentially avoidable through the maintenance of optimal levels of classic cardiovascular risk factors, further reinforcing the need for effective primary prevention strategies that enable individuals to adopt and maintain healthy diet and behavioral patterns.
Conclusion:
As with other forms of cardiovascular disease, more than half of the AF burden is potentially avoidable through the optimization of cardiovascular risk factors levels. 29
Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study
Summary: Cardiac troponin T (cTnT) and troponin I are the biomarkers of choice in the evaluation of patients with acute coronary syndromes. Cardiac troponin has been independently associated with adverse outcomes after acute coronary syndrome, in patients with chronic heart failure, and in the general population, although cTnT levels are detectable in only a small fraction of the general population with the use of current assays. A precommercial highly sensitive cTnT assay can detect 10-fold lower concentrations than currently available assays. We sought to define the prevalence of measurable cTnT using this new highly sensitive assay and the associations of cTnT levels with adverse cardiovascular events in participants in the Atherosclerosis Risk in Communities (ARIC) Study, aged 54 to 74 years, who were initially free of cardiovascular disease. We found that the new highly sensitive cTnT assay detected circulating cTnT in 66.5% of the ARIC sample (Ͻ1% would have been detected by the currently available cTnT assays) and that measured cTnT had strong associations with coronary heart disease events, mortality, and heart failure and improved risk prediction. cTnT appears to be an important marker of coronary heart disease, mortality, and heart failure risk even in a healthy middle-aged population without manifest cardiovascular disease.
Conclusions: cTnT detectable with a highly sensitive assay was associated with incident CHD, mortality, and HF in individuals from a general population without known coronary heart disease/stroke. 30
Association of Incident Cardiovascular Disease With Progression of Sleep-Disordered Breathing
Summary: Sleep-disordered breathing has been associated with incident cardiovascular disease. The possibility that incident cardiovascular disease may cause or worsen sleep-disordered breathing (eg, by altering ventilatory control) has not been evaluated. We assessed this possibility in the community-based Sleep Heart Health Study. In this study, incident cardiovascular disease was associated with a more rapid progression of both obstructive and central sleep-disordered breathing over a 5-year follow-up period. This association is most pronounced in subjects with body mass index Ͻ30 and apnea-hypopnea index Ͼ5 events per hour at baseline. This finding suggests that the association between sleep-disordered breathing and cardiovascular disease may be bidirectional.
Conclusions:
In a diverse, community-based sample of middle-aged and older adults, incident cardiovascular disease was associated with worsening sleep-disordered breathing over 5 years. 31
Low Prevalence of "Ideal Cardiovascular Health" in a Community-Based Population: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study
Summary: The American Heart Association (AHA)'s 2020 Impact Goal focuses on promotion of health and control of risk rather than solely on prevention and treatment of specific cardiovascular diseases. This goal includes a new construct of cardiovascular health composed of seven behaviors and factors. Our study is the first report of the application of this construct to a cohort of black and white participants in a community-based cardiovascular prevention study. Only one out 1933 participants met all 7 components of the AHAs definition of ideal cardiovascular health. The indices of ideal health behaviors and ideal health factors were only met by 2.0% and 1.4% of participants, respectively. The large gap between the prevalence of ideal cardiovascular health and the AHAs goals was consistently identified in all subgroups evaluated by age, race, sex, education and income level. Although black race emerged as an important independent determinant of the lack of achievement of "ideal cardiovascular health," both whites and blacks have a long way to goal. Our findings suggest that the attainment of the stated goals for the next decade may be more challenging than originally conceived. Practicing clinicians and their health care teams need to engage in coordinated efforts along with social sciences professionals, policymakers, and individuals and their communities in order to ensure the achievement of these goals.
Conclusion:
The prevalence of ideal cardiovascular health is extremely low in a middle-aged community-based study population. Comprehensive individual and population-based interventions must be developed to support the attainment of the AHAs 2020 Impact Goal for cardiovascular health. 32
Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease
Summary: Celiac disease (CD) is an immune-mediated disease that occurs in some 1% of the Western population. Triggered by exposure to gluten, CD is characterized by small intestinal villous atrophy and inflammation. Ischemic heart disease (IHD) is one of the main causes of death. The underlying pathology in IHD is atherosclerosis, and it seems that chronic inflammation plays an important role in the development of atherosclerosis. The present study found a 19% increased risk of IHD in individuals with CD. This study also found a 28% increased risk of IHD in individuals with small intestinal inflammation but no villous atrophy and a 14% increase in individuals with normal mucosa but positive CD serology (latent CD). This corresponded to excess risks of 60 per 100 000 person-years in CD (179 in inflammation and 31 in latent CD). Some 16% of all IHD in patients with CD could be attributed to the underlying CD. Because cardiovascular disease is the most common cause of death in this group of patients, our findings may have important implications in patients with CD. Increased awareness of IHD risk factors in this patient group is warranted, and if our findings are corroborated by others, clinical guidelines of treatment of CD may have to include a more detailed cardiovascular risk assessment than what is current practice.
Conclusions: Individuals with CD or small intestinal inflammation are at increased risk of incident IHD. We were unable to show a positive association between latent CD and incident IHD. 33
Association of Maternal Diabetes Mellitus in Pregnancy With Offspring Adiposity Into Early Adulthood: Sibling Study in a Prospective Cohort of 280 866 Men From 248 293 Families
Summary: Maternal diabetes mellitus in pregnancy results in greater offspring adiposity at birth. However, it is unclear whether it results in greater adiposity into adulthood in humans. We undertook a large record-linkage prospective-cohort study of 280 866 singleton-born Swedish men from 248 293 families in order to explore the intrauterine effect of maternal diabetes mellitus on offspring body mass index (BMI) in early adulthood. Maternal diabetes mellitus during pregnancy was associated with greater mean BMI at age 18 in their sons. The difference in BMI was similar within brothers and between unrelated individuals. BMI of men whose mothers had diabetes mellitus during their pregnancy was on average 0.94 kg/m 2 greater (95% confidence interval, 0.35-1.52) than in their brothers born before their mother was diagnosed with diabetes. This association was independent of maternal early-pregnancy BMI. Our results show that maternal diabetes mellitus in pregnancy has long-term consequences that are, at least in part, driven by intrauterine mechanisms for greater BMI in offspring. These findings highlight the clinical importance of identifying and adequately treating gestational diabetes mellitus not only for the short-term health benefit of mother and baby, but also potentially for the longer-term prevention of obesity in offspring.
Conclusion:
Maternal diabetes mellitus has long-term consequences for greater BMI in offspring; this association is likely to be via intrauterine mechanisms, and is independent of maternal BMI in early pregnancy. 34
Consumption of Added Sugars and Indicators of Cardiovascular Disease Risk Among US Adolescents
Summary: Consumption of added sugars (caloric sweeteners), which contribute calories but no other nutrients to the diet, are the source of more than one fifth of the calories consumed by US adolescents. The results of our study show that higher consumption of these sugars is associated with blood lipid levels that may place adolescents at increased risk of future cardiovascular disease. We also found that the risks associated with added sugar consumption may be higher among overweight or obese adolescents because higher consumption among this group was also associated with increased insulin resistance. Our findings highlight the prominence of added sugars in the e154 Circulation September 4, 2012 diets of adolescents and suggest that reducing this consumption could be a strategy for modifying cardiovascular disease risk factors and helping to prevent cardiovascular disease. The associations demonstrated in our cross-sectional study point to the need for controlled trials to determine if reducing consumption of added sugars can improve cardiovascular disease risk factors in adolescents and prevent future disease.
Conclusion: Consumption of added sugars among US adolescents is positively associated with multiple measures known to increase cardiovascular disease risk. 35 
Microvascular Function Predicts Cardiovascular Events in Primary Prevention: Long-Term Results From the Firefighters and Their Endothelium (FATE) Study
Summary: The endothelium plays a prominent role in vascular homeostasis and in health inhibits atherosclerosis formation and its complications. Conduit vessel function can be readily measured noninvasively by assessing flow-mediated dilation after a hyperemic stimulus. Blood flow at the tissue level determines organ viability and is controlled mainly at the microvascular level. Thus, there has been recent interest in measures of microvascular function and its clinical relevance. In the present study, we demonstrated in a large, long-term, prospective cohort of healthy men a number of important and novel findings. First, unlike some previous studies, flowmediated dilation was not associated with vascular events. However, the hyperemic stimulus was an independent risk marker after Framingham risk score was considered. Second, carotid intimamedia thickness was also associated with events, and this association remained after correction for Framingham risk and the hyperemic stimulus. This suggests that measures of both structure and microvascular function are risk predictors for adverse outcomes and provide synergistic information. The present study adds further evidence to the literature that these end points are surrogate measures of atherosclerosis outcomes and can be used in clinical research. Finally, because hyperemic velocity is a readily measured outcome variable, it has the potential to be incorporated into clinical care if further studies support our reported association. This would be most applicable to intermediate-risk individuals in whom additional testing has been advocated for clinical decision making.
Conclusions:
In men, hyperemic velocity, the stimulus for flowmediated dilation, but not flow-mediated dilation itself was a significant risk marker for adverse cardiovascular outcomes. The prognostic value was additive to traditional risk factors and carotid intima-media thickness. Hyperemic velocity, a newly described marker of microvascular function, is a novel tool that may improve risk stratification of lower-risk healthy men. 36 
